DD206994A5 - Verfahren zur herstellung von pyridinderivaten - Google Patents

Verfahren zur herstellung von pyridinderivaten Download PDF

Info

Publication number
DD206994A5
DD206994A5 DD83248919A DD24891983A DD206994A5 DD 206994 A5 DD206994 A5 DD 206994A5 DD 83248919 A DD83248919 A DD 83248919A DD 24891983 A DD24891983 A DD 24891983A DD 206994 A5 DD206994 A5 DD 206994A5
Authority
DD
German Democratic Republic
Prior art keywords
group
general formula
compound
compounds
radicals
Prior art date
Application number
DD83248919A
Other languages
German (de)
English (en)
Inventor
David G Cooper
George S Sach
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DD206994A5 publication Critical patent/DD206994A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/58Amidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD83248919A 1982-03-17 1983-03-17 Verfahren zur herstellung von pyridinderivaten DD206994A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8207835 1982-03-17
GB8209540 1982-03-31

Publications (1)

Publication Number Publication Date
DD206994A5 true DD206994A5 (de) 1984-02-15

Family

ID=26282275

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83248919A DD206994A5 (de) 1982-03-17 1983-03-17 Verfahren zur herstellung von pyridinderivaten

Country Status (17)

Country Link
US (3) US4551466A (pt)
EP (2) EP0089765A3 (pt)
AU (2) AU1254283A (pt)
CA (1) CA1192191A (pt)
DD (1) DD206994A5 (pt)
DE (1) DE3366369D1 (pt)
DK (2) DK123083A (pt)
ES (1) ES520709A0 (pt)
FI (1) FI830891L (pt)
GR (2) GR77155B (pt)
IL (1) IL68130A0 (pt)
JO (1) JO1244B1 (pt)
NO (1) NO830932L (pt)
PL (1) PL241052A1 (pt)
PT (1) PT76395B (pt)
RO (1) RO85384B (pt)
ZW (1) ZW6883A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
ATE496032T1 (de) 1999-02-24 2011-02-15 Hoffmann La Roche 4-phenylpyridinderivate und deren verwendung als nk-1 rezeptorantagonisten
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
TWI280239B (en) 2003-07-15 2007-05-01 Hoffmann La Roche Process for preparation of pyridine derivatives
US7423147B2 (en) 2004-03-31 2008-09-09 Janssen Pharmaceutical, N.V. Pyridine compounds as histamine H3 modulators
DK1928427T3 (da) 2005-09-23 2010-03-08 Hoffmann La Roche Hidtil ukendt dosisformulering
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CA2706328C (en) 2007-11-20 2016-04-19 Janssen Pharmaceutica N.V. Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
GB2063874B (en) * 1979-10-22 1983-09-28 Glaxo Group Ltd Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them
EP0029303B1 (en) * 1979-10-22 1985-01-30 Glaxo Group Limited 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors

Also Published As

Publication number Publication date
IL68130A0 (en) 1983-06-15
GR77155B (pt) 1984-09-07
DK123183A (da) 1983-09-18
EP0089153B1 (en) 1986-09-24
DE3366369D1 (en) 1986-10-30
PT76395B (en) 1985-12-05
NO830932L (no) 1983-09-19
RO85384B (ro) 1984-11-30
ES8500935A1 (es) 1984-11-01
EP0089765A2 (en) 1983-09-28
AU1254283A (en) 1983-09-22
GR77162B (pt) 1984-09-10
ZW6883A1 (en) 1983-06-08
US4551466A (en) 1985-11-05
RO85384A (ro) 1984-11-25
US4574126A (en) 1986-03-04
EP0089765A3 (en) 1984-05-23
US4758576A (en) 1988-07-19
PT76395A (en) 1983-04-01
DK123083A (da) 1983-09-18
DK123083D0 (da) 1983-03-17
JO1244B1 (en) 1985-04-20
DK123183D0 (da) 1983-03-17
CA1192191A (en) 1985-08-20
ES520709A0 (es) 1984-11-01
EP0089153A2 (en) 1983-09-21
FI830891L (fi) 1983-09-18
FI830891A0 (fi) 1983-03-17
AU1254183A (en) 1983-09-22
PL241052A1 (en) 1984-05-21
EP0089153A3 (en) 1984-07-11

Similar Documents

Publication Publication Date Title
DE3781845T2 (de) Benzimidazol-derivate.
DE69837675T2 (de) Pyrazolderivate
DE3873127T2 (de) Therapeutische praeparate.
DD224593A5 (de) Verfahren zur herstellung von 1-heteroaryl-4-[-2,5-pyrrolidindion-1-yl]alkyl]piperazinderivaten
CH649539A5 (de) Antidepressiv wirksame piperazinylalkyl-1,2,4-triazol-3-one.
CH647767A5 (de) Triazolverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DD211340A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DE2928842A1 (de) Pyrimidonderivate
EP0129791A2 (de) Tetrahydropyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0335381A1 (de) Neue 2,3,4-substituierte Imidazole und 3,4,5-substituierte 1,2,4-Triazole, ihre Herstellung und Verwendung
EP0772593B1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
CH645892A5 (de) Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel.
DE4036645A1 (de) Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung
DD206994A5 (de) Verfahren zur herstellung von pyridinderivaten
DE3442860A1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3107628A1 (de) Heterocyclische derivate
DE60107586T2 (de) Substituierte imidazole als duale histamine h1 und h3 agonisten oder antagonisten
DE3601143A1 (de) Cyclische imidderivate von 2-(4-butylpiperazin-1-yl)-pyridinen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE3615180A1 (de) Disubstituierte 1,4-piperazinylderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE3802362A1 (de) Tetrahydrofuranderivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DD144916A5 (de) Verfahren zur herstellung von pyrimidinverbindungen und ihren salzen
DE3808283A1 (de) Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung
DE2559211A1 (de) Substituierte indole
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DD157703A5 (de) Verfahren zur herstellung von pyrimidonderivaten